GB201004101D0 - Immobilised biological entities - Google Patents

Immobilised biological entities

Info

Publication number
GB201004101D0
GB201004101D0 GBGB1004101.0A GB201004101A GB201004101D0 GB 201004101 D0 GB201004101 D0 GB 201004101D0 GB 201004101 A GB201004101 A GB 201004101A GB 201004101 D0 GB201004101 D0 GB 201004101D0
Authority
GB
United Kingdom
Prior art keywords
biological entities
immobilised biological
immobilised
entities
biological
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1004101.0A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Carmeda AB
Original Assignee
Carmeda AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carmeda AB filed Critical Carmeda AB
Priority to GBGB1004101.0A priority Critical patent/GB201004101D0/en
Publication of GB201004101D0 publication Critical patent/GB201004101D0/en
Priority to ES11708813.8T priority patent/ES2644369T3/es
Priority to AU2011225982A priority patent/AU2011225982B2/en
Priority to US13/045,769 priority patent/US8501212B2/en
Priority to CA2791545A priority patent/CA2791545C/en
Priority to PCT/EP2011/053745 priority patent/WO2011110684A1/en
Priority to EP11708813.8A priority patent/EP2544728B1/en
Priority to JP2012556539A priority patent/JP5960612B2/ja
Priority to US13/911,727 priority patent/US10016512B2/en
Priority to JP2016124560A priority patent/JP6683551B2/ja
Priority to US15/798,215 priority patent/US10842880B2/en
Priority to JP2018034545A priority patent/JP6693983B2/ja
Priority to JP2020073602A priority patent/JP2020108864A/ja
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6957—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a device or a kit, e.g. stents or microdevices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A61L33/0029—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate using an intermediate layer of polymer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
GBGB1004101.0A 2010-03-12 2010-03-12 Immobilised biological entities Ceased GB201004101D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB1004101.0A GB201004101D0 (en) 2010-03-12 2010-03-12 Immobilised biological entities
JP2012556539A JP5960612B2 (ja) 2010-03-12 2011-03-11 固定された生物学的実体
EP11708813.8A EP2544728B1 (en) 2010-03-12 2011-03-11 Immobilised biological entities
AU2011225982A AU2011225982B2 (en) 2010-03-12 2011-03-11 Immobilised biological entities
US13/045,769 US8501212B2 (en) 2010-03-12 2011-03-11 Immobilised biological entities
CA2791545A CA2791545C (en) 2010-03-12 2011-03-11 Immobilised biological entities
PCT/EP2011/053745 WO2011110684A1 (en) 2010-03-12 2011-03-11 Immobilised biological entities
ES11708813.8T ES2644369T3 (es) 2010-03-12 2011-03-11 Entidades biológicas inmovilizadas
US13/911,727 US10016512B2 (en) 2010-03-12 2013-06-06 Immobilised biological entities
JP2016124560A JP6683551B2 (ja) 2010-03-12 2016-06-23 固定された生物学的実体
US15/798,215 US10842880B2 (en) 2010-03-12 2017-10-30 Immobilised biological entities
JP2018034545A JP6693983B2 (ja) 2010-03-12 2018-02-28 固定された生物学的実体
JP2020073602A JP2020108864A (ja) 2010-03-12 2020-04-16 固定された生物学的実体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1004101.0A GB201004101D0 (en) 2010-03-12 2010-03-12 Immobilised biological entities

Publications (1)

Publication Number Publication Date
GB201004101D0 true GB201004101D0 (en) 2010-04-28

Family

ID=42261450

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1004101.0A Ceased GB201004101D0 (en) 2010-03-12 2010-03-12 Immobilised biological entities

Country Status (8)

Country Link
US (3) US8501212B2 (https=)
EP (1) EP2544728B1 (https=)
JP (4) JP5960612B2 (https=)
AU (1) AU2011225982B2 (https=)
CA (1) CA2791545C (https=)
ES (1) ES2644369T3 (https=)
GB (1) GB201004101D0 (https=)
WO (1) WO2011110684A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0816783D0 (en) 2008-09-15 2008-10-22 Carmeda Ab Immobilised biological entities
GB201004101D0 (en) 2010-03-12 2010-04-28 Carmeda Ab Immobilised biological entities
EP2683420B1 (en) 2011-03-11 2018-05-23 W. L. Gore & Associates, Inc. Improvements to immobilised biological entities
US11839698B2 (en) 2014-03-13 2023-12-12 W. L. Gore & Associates, Inc. Drug composition and coating
US10561766B2 (en) 2015-09-15 2020-02-18 W. L. Gore & Associates, Inc. Drug composition and coating
WO2019170859A2 (en) 2018-03-09 2019-09-12 Carmeda Ab Improvements to immobilising biological entities
AU2019232163B2 (en) 2018-03-09 2025-11-20 Carmeda Ab Improvements to processes for immobilising biological entities
AU2019354085B2 (en) 2018-10-03 2025-06-05 Carmeda Ab Immobilised biological entities
WO2020190214A1 (en) 2019-03-19 2020-09-24 Jmedtech Coating Technologies Pte Ltd Medical device comprising covalently bonded heparin coating
AU2021324051A1 (en) * 2020-08-14 2023-02-09 Idris Oncology B.V. A process for applying a coating comprising one or more polysaccharides with binding affinity for bioanalytes onto the surface of a medical sampling device, and the medical sampling device for capture of bioanalytes provided with the coating
CN114470324B (zh) * 2022-02-08 2023-04-04 福建医科大学附属协和医院 通用的骨植入物改性新策略用于伴糖尿病骨缺损的干预

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4919202B1 (https=) 1968-05-14 1974-05-16
US3852253A (en) * 1972-12-22 1974-12-03 Exxon Research Engineering Co Heterogeneous process for preparing conjugated diene butyl
SE456347B (sv) 1982-02-09 1988-09-26 Ird Biomaterial Ab Ytmodifierat fast substrat samt forfarande for framstellning derav
SE8200751L (sv) 1982-02-09 1983-08-10 Olle Larm Forfarande for kovalent koppling for framstellning av konjugat och hervid erhallna produkter
JP2710444B2 (ja) 1989-09-18 1998-02-10 旭化成工業株式会社 医療材料の製造法
US5213898A (en) * 1989-10-12 1993-05-25 Norsk Hydro A.S. Process for the preparation of surface modified solid substrates
US5049403A (en) 1989-10-12 1991-09-17 Horsk Hydro A.S. Process for the preparation of surface modified solid substrates
DE19604173C2 (de) 1996-02-06 2000-07-06 Hartwig Hoecker Verfahren zur Erzeugung antithrombogener Oberflächen auf extrakorporal und/oder intrakorporal zu verwendenden medizinischen Gegenständen
US6200955B1 (en) 1996-06-11 2001-03-13 Commonwealth Biotechnologies, Inc. Heparin binding peptides
JP3188868B2 (ja) 1997-07-02 2001-07-16 昌子 小田切 金属線たわし
FR2772770B1 (fr) * 1997-12-19 2000-01-28 Oreal Nouveaux composes choisis parmi les polymeres hyperbranches et les dendrimeres ayant un groupement particulier, procede de preparation, utilisation et compositions les comprenant
NO984143L (no) 1998-09-09 2000-03-10 Norsk Hydro As Ny prosess for å fremstille overflatemodifiserende stoffer
SE515295C2 (sv) * 1999-11-23 2001-07-09 Medicarb Ab Förfarande för framställning av konjugat av en biologiskt aktiv polysackarid och ett fast substrat, samt sådana konjugat
KR100378109B1 (ko) * 2000-10-24 2003-03-29 주식회사 메디프렉스 소수성 다중복합 헤파린 결합체, 그의 제조방법 및 용도
US6509104B2 (en) * 2000-12-05 2003-01-21 Michigan Biotechnology Institute Antithrombogenic polymer coating
US20050059068A1 (en) * 2001-05-23 2005-03-17 Stratagene California Compositions and methods using dendrimer-treated microassays
CA2460928A1 (en) 2001-09-18 2003-03-27 Eidgenossische Technische Hochschule Zurich Methods and apparatus for coating surfaces
US7163553B2 (en) * 2001-12-28 2007-01-16 Advanced Cardiovascular Systems, Inc. Intravascular stent and method of use
DE10393059D2 (de) * 2002-05-09 2005-05-04 Hemoteq Gmbh Verbindungen und Verfahren zur hemokompatiblen Beschichtung von Oberflächen
AU2003240482B2 (en) * 2002-05-30 2009-03-12 The Scripps Research Institute Copper-catalysed ligation of azides and acetylenes
FR2845279B1 (fr) 2002-10-04 2006-06-16 Oreal Utilisation de latex cationiques non filmogenes pour l'augmentation de volume de la chevelure.
US20040115151A1 (en) 2002-10-04 2004-06-17 Franck Giroud Use of non-film-forming cationic latices for increasing the volume of the hair
JP2004189724A (ja) 2002-11-29 2004-07-08 Toray Ind Inc 生理活性物質を含む材料およびその製造方法
JP2004189627A (ja) 2002-12-09 2004-07-08 Toray Ind Inc リガンドの脱離可能なリガンド−カチオン性ポリマー複合体および、該ポリマー複合体を固定化させた材料およびそれを用いたカラム
US20050032081A1 (en) * 2002-12-13 2005-02-10 Jingyue Ju Biomolecular coupling methods using 1,3-dipolar cycloaddition chemistry
PL1603603T3 (pl) * 2003-02-28 2015-07-31 Biointeractions Ltd System sieci polimerowych dla urządzeń medycznych oraz sposoby zastosowania
US9561309B2 (en) * 2004-05-27 2017-02-07 Advanced Cardiovascular Systems, Inc. Antifouling heparin coatings
KR20070037513A (ko) * 2004-07-22 2007-04-04 더 스크립스 리서치 인스티튜트 클릭 화학을 통한 중합체성 물질
EP1904553A4 (en) 2005-07-06 2013-04-24 Molly S Shoichet METHOD OF IMMOBILIZING BIOMOLECULE ON POLYMERS INVOLVING FAST TYPE CHEMICAL REACTIONS
US20070020620A1 (en) * 2005-07-14 2007-01-25 Finn M G Compositions and methods for coupling a plurality of compounds to a scaffold
KR20080067619A (ko) 2005-09-15 2008-07-21 유니버시티 오브 유타 리써치 파운데이션 고분자 조성물 및 이의 제조방법, 및 이의 용도
US7811555B2 (en) 2005-12-30 2010-10-12 Cordis Corporation Tri-branched biologically active copolymer
US8986713B2 (en) 2006-05-12 2015-03-24 W. L. Gore & Associates, Inc. Medical device capable of being compacted and expanded having anti-thrombin III binding activity
US8021677B2 (en) 2006-05-12 2011-09-20 Gore Enterprise Holdings, Inc. Immobilized biologically active entities having a high degree of biological activity
EP2052045A4 (en) 2006-08-18 2012-09-12 Commw Scient Ind Res Org POLYMERIC COATINGS AND METHODS FOR FORMING SAME
ITMI20061726A1 (it) 2006-09-11 2008-03-12 Fidia Farmaceutici Derivati crosslinkati a base di acido ialuronico reticolato via click chemistry
WO2008090555A2 (en) 2007-01-22 2008-07-31 Elutex Ltd. Medical devices having a matrix adhered thereof
US20090018646A1 (en) * 2007-07-10 2009-01-15 Zhao Jonathon Z Coating Employing an Anti-Thrombotic Conjugate
FR2920436A1 (fr) 2007-08-30 2009-03-06 Rhodia Operations Sas Composition de traitement de fils ou fibres d'articles textiles
US8153268B1 (en) * 2008-03-26 2012-04-10 Loctite (R&D) Limited Polymer to metal bonding and compounds and compositions useful therefor
GB0816783D0 (en) 2008-09-15 2008-10-22 Carmeda Ab Immobilised biological entities
EP2352796A1 (en) 2008-12-05 2011-08-10 Semprus Biociences Corporation Layered non-fouling, antimicrobial, antithrombogenic coatings
NZ593201A (en) * 2008-12-05 2013-05-31 Semprus Biosciences Corp Non-fouling, anti-microbial, anti-thrombogenic graft-from compositions
CN101649011B (zh) * 2009-08-13 2011-01-19 同济大学 硫醇-烯点击化学功能化超支化聚乙烯亚胺的制备方法
JP2011092491A (ja) * 2009-10-30 2011-05-12 Kanazawa Inst Of Technology 埋め込み部材
GB201004101D0 (en) 2010-03-12 2010-04-28 Carmeda Ab Immobilised biological entities

Also Published As

Publication number Publication date
US8501212B2 (en) 2013-08-06
US10842880B2 (en) 2020-11-24
US20110223229A1 (en) 2011-09-15
AU2011225982B2 (en) 2014-09-04
US20180140713A1 (en) 2018-05-24
AU2011225982A1 (en) 2012-09-20
CA2791545C (en) 2018-12-11
ES2644369T3 (es) 2017-11-28
US20160228572A9 (en) 2016-08-11
JP2020108864A (ja) 2020-07-16
JP5960612B2 (ja) 2016-08-02
EP2544728A1 (en) 2013-01-16
EP2544728B1 (en) 2017-07-19
JP2016193219A (ja) 2016-11-17
JP6683551B2 (ja) 2020-04-22
JP2018099543A (ja) 2018-06-28
JP6693983B2 (ja) 2020-05-13
US20130273122A1 (en) 2013-10-17
CA2791545A1 (en) 2011-09-15
US10016512B2 (en) 2018-07-10
JP2013521838A (ja) 2013-06-13
WO2011110684A1 (en) 2011-09-15

Similar Documents

Publication Publication Date Title
PL2556171T3 (pl) Oznaczenia biologiczne kodowane przestrzennie
ZA201209004B (en) Anti-fgfr2 antibodies
GB201000467D0 (en) Antibodies
GB201005063D0 (en) Biological products
IL221371A0 (en) Anti-lrp6 antibodies
ZA201302459B (en) Antibodies
GB0816783D0 (en) Immobilised biological entities
GB201004101D0 (en) Immobilised biological entities
GB201020738D0 (en) Antibodies
GB201102513D0 (en) No title
PL2603528T3 (pl) Przeciwciała Fab-glikozylowane
GB201017575D0 (en) No title
GB201002238D0 (en) Antibodies
GB201002082D0 (en) Biological material
ZA201208369B (en) Pipette
GB201021711D0 (en) Assay
GB201105798D0 (en) No title
GB201004306D0 (en) Assay
GB201002382D0 (en) Assay
GB201009658D0 (en) Incubator
GB201106585D0 (en) No title
GB201000171D0 (en) Biological methods
GB201018989D0 (en) Biological methods
GB201002924D0 (en) Biosensor
GB201110726D0 (en) Improvements to immobilised biological entities

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)